Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxazosin for PTSD Nightmares and Sleep Disturbance
NCT03339258Phase 2Active, not recruiting
- Sponsor
- San Francisco VA Medical Center
- Start
- Apr 2018
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of doxazosin in post-traumatic stress disorder (PTSD), sponsored by San Francisco VA Medical Center. Started Apr 2018; status: active, not recruiting.
02
Drugs
doxazosin
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT03339258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03339258.